Q1 2017 · —
Revenue$14.85M$14.85M no prior Q1 2016 on file
Net Income-$1.11M-$1.11M no prior Q1 2016 on file
EPS Diluted-$2.55-$2.55 no prior Q1 2016 on file
Margins · derived
Net margin-7.5%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q1 2016 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sutro Biopharma, Inc. · CIK 1382101 · Engraved from SEC EDGAR